We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.18B
AUM Growth
+$413M
Cap. Flow
+$293M
Cap. Flow %
7.01%
Top 10 Hldgs %
6.7%
Holding
1,500
New
123
Increased
567
Reduced
324
Closed
123

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$20M
2
NVDA icon
NVIDIA
NVDA
+$19M
3
JNJ icon
Johnson & Johnson
JNJ
+$14.9M
4
KO icon
Coca-Cola
KO
+$14.6M
5
MSFT icon
Microsoft
MSFT
+$13.7M

Sector Composition

Rank Sector Weight
1 Financials 24.63%
2 Consumer Discretionary 12.15%
3 Technology 12.08%
4 Industrials 12%
5 Healthcare 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRLD icon
1176
Prelude Therapeutics
PRLD
$373M
$166K ﹤0.01%
36,949
FRBK
1177
DELISTED
Republic First Bancorp Inc
FRBK
$165K ﹤0.01%
+183,200
New +$210K
MPTI icon
1178
M-tron Industries
MPTI
$382M
$162K ﹤0.01%
14,600
DC icon
1179
Dakota Gold
DC
$739M
$161K ﹤0.01%
55,000
SPRO icon
1180
Spero Therapeutics
SPRO
$73.5M
$159K ﹤0.01%
109,800
LUMO
1181
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$157K ﹤0.01%
47,643
IDN icon
1182
Intellicheck
IDN
$76.8M
$156K ﹤0.01%
63,200
WYY icon
1183
WidePoint Corp
WYY
$106M
$156K ﹤0.01%
83,898
+620
+0.7% +$1.15K
CLYM
1184
Climb Bio
CLYM
$802M
$155K ﹤0.01%
55,223
TARA icon
1185
Protara Therapeutics
TARA
$230M
$153K ﹤0.01%
64,000
CLPR
1186
Clipper Realty
CLPR
$45.2M
$152K ﹤0.01%
26,863
+8,000
+42% +$43.6K
APLT
1187
DELISTED
Applied Therapeutics
APLT
$152K ﹤0.01%
118,800
MXC icon
1188
Mexco Energy
MXC
$19.4M
$152K ﹤0.01%
12,660
-1,908
-13% -$22.3K
FGH
1189
DELISTED
FG Group Holdings Inc.
FGH
$151K ﹤0.01%
78,900
SGRP
1190
DELISTED
SPAR Group
SGRP
$151K ﹤0.01%
120,200
ZVIA icon
1191
Zevia
ZVIA
$106M
$151K ﹤0.01%
35,000
NAUT icon
1192
Nautilus Biotechnolgy
NAUT
$113M
$150K ﹤0.01%
38,800
YELL
1193
DELISTED
Yellow Corporation Common Stock
YELL
$149K ﹤0.01%
215,649
-39,551
-15% -$61.8K
CRGE
1194
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$147K ﹤0.01%
150,500
+50,000
+50% +$50.8K
BCEL
1195
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$147K ﹤0.01%
150,000
+50,000
+50% +$51.5K
EIGR
1196
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$146K ﹤0.01%
6,890
+3,333
+94% +$103K
VRM icon
1197
Vroom Inc
VRM
$48.3M
$144K ﹤0.01%
+1,250
New +$95.3K
BBGI icon
1198
Beasley Broadcasting Group
BBGI
$42.8M
$143K ﹤0.01%
6,991
-4,321
-38% -$83.1K
SBEV icon
1199
Splash Beverage Group
SBEV
$2.81M
$143K ﹤0.01%
796
+157
+25% +$28.7K
FFWM
1200
DELISTED
First Foundation Inc
FFWM
$142K ﹤0.01%
35,880
-52,620
-59% -$271K

Similar funds

Bridgeway Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Bridgeway Capital Management held 1,500 positions worth $4.18B, up 11% from $3.77B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

Bridgeway Capital Management deployed $293M of net new capital in Q2 2023, opening 123 new positions and adding to 567 existing holdings. Its largest new stake was Tronox: 919,025 shares worth $11.7M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Permian Resources, an estimated $14.3M trimmed.

  • Bridgeway Capital Management's largest Q2 2023 buy was Tronox: 919,025 shares worth $11.7M.
  • Bridgeway Capital Management added most to JPMorgan Chase in Q2 2023, an estimated $20M increase.
  • Bridgeway Capital Management's biggest Q2 2023 reduction was Permian Resources, cutting an estimated $14.3M.
  • Bridgeway Capital Management fully exited TravelCenters of America LLC in Q2 2023, selling an estimated $21.5M.
  • Bridgeway Capital Management's ten largest holdings make up 6.7% of its $4.18B portfolio in Q2 2023.
  • Bridgeway Capital Management opened 123 new positions and closed 123 in Q2 2023.
  • Bridgeway Capital Management's portfolio value rose 11% quarter-over-quarter to $4.18B.

Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.